Abstract:Background:Ensuring the survival of the distal end of a random flap during hypoperfusion (ischaemia) is difficult in clinical practice. Effective prevention of programmed cell death is a potential strategy for inhibiting ischaemic flap necrosis. The activation of stimulator of interferon genes (STING) pathway promotes inflammation and leads to cell death. The epidermal growth factor family member neuregulin-1 (NRG1) reduces cell death by activating the protein kinase B (AKT) signalling pathway. Moreover, AKT signalling negatively regulates STING activity. We aimed to verify the efficacy of NRG1 injection in protecting against flap necrosis. Additionally, we investigated whether NRG1 effectively enhances ischemic flap survival by inhibiting pyroptosis and necroptosis through STING suppression.Methods:A random-pattern skin flap model was generated on the backs of C57BL/6 mice. The skin flap survival area was determined. The blood supply and vascular network of the flap was assessed by laser Doppler blood flow analysis. Cluster of differentiation 34 immunohistochemistry (IHC) and haematoxylin and eosin (H&E) staining of the flap sections revealed microvessels. Transcriptome sequencing analysis revealed the mechanism by which NRG1 promotes the survival of ischaemic flaps. The levels of angiogenesis, oxidative stress, necroptosis, pyroptosis and indicators associated with signalling pathways in flaps were examined by IHC, immunofluorescence and Western blotting. Packaging adeno-associated virus (AAV) was used to activate STING in flaps.Results:NRG1 promoted the survival of ischaemic flaps. An increased subcutaneous vascular network and neovascularization were found in ischaemic flaps after the application of NRG1. Transcriptomic gene ontology enrichment analysis and protein level detection indicated that necroptosis, pyroptosis and STING activity were reduced in the NRG1 group. The phosphorylation of AKT and forkhead box O3a (FOXO3a) were increased after NRG1 treatment. The increased expression of STING in flaps induced by AAV reversed the therapeutic effect of NRG1. The ability of NRG1 to phosphorylate AKT-FOXO3a, inhibit STING and promote flap survival was abolished after the application of the AKT inhibitor MK2206.Conclusions:NRG1 inhibits pyroptosis and necroptosis by activating the AKT-FOXO3a signalling pathway to suppress STING activation and promote ischaemic flap survival.

Naringenin reduces oxidative stress and necroptosis, apoptosis, and pyroptosis in random-pattern skin flaps by enhancing autophagy

Naringenin Protects Against Septic Cardiomyocyte Injury Via PI3K- AKT Signaling Pathway

Neuregulin-1, a Member of the Epidermal Growth Factor Family, Mitigates STING-mediated Pyroptosis and Necroptosis in Ischaemic Flaps

Nuciferine improves random skin flap survival via TFEB-mediated activation of autophagy-lysosomal pathway

Puerarin enhances TFEB-mediated autophagy and attenuates ROS-induced pyroptosis after ischemic injury of random-pattern skin flaps

Pinocembrin alleviates pyroptosis and apoptosis through ROS elimination in random skin flaps via activation of SIRT3

Therapeutic potential of naringin in improving the survival rate of skin flap: A review

Procyanidin B2 regulates the Sirt1/Nrf2 signaling pathway to improve random‐pattern skin flap survival

Activation of aldehyde dehydrogenase-2 improves ischemic random skin flap survival in rats

Positive Effect of Andrographolide Induced Autophagy on Random-Pattern Skin Flaps Survival

FGF21 augments autophagy in random-pattern skin flaps via AMPK signaling pathways and improves tissue survival

Paeoniflorin Suppresses TBHP-Induced Oxidative Stress and Apoptosis in Human Umbilical Vein Endothelial Cells Via the Nrf2/HO-1 Signaling Pathway and Improves Skin Flap Survival

Effect of paeoniflorin on distal survival of random flaps

Catalpol Enhances Random-Pattern Skin Flap Survival by Activating SIRT1-Mediated Enhancement of Autophagy

Naringenin Alleviates Renal Ischemia Reperfusion Injury by Suppressing ER Stress-Induced Pyroptosis and Apoptosis through Activating Nrf2/HO-1 Signaling Pathway

Zingerone Promotes the Survival of Ischaemic Flap Via the KEAP1-Nrf2 Pathway

Rosuvastatin Promotes Survival of Random Skin Flaps Through AMPK-mTOR Pathway-Induced Autophagy.

Curcumin promotes the survival of ischemic random skin flaps via autophagy

Caffeic Acid-Vanadium Nanozymes Treat Skin Flap Ischemia-Reperfusion Injury Through Macrophage Reprogramming and the Upregulation of X-linked Inhibitors of Apoptotic Proteins

Tetrandrine promotes the survival of the random skin flap via the PI3K/AKT signaling pathway

Tetrahydropalmatine promotes random skin flap survival in rats via the PI3K/AKT signaling pathway